Japan Tobacco Inc.

July is inextricably linked with Independence Day in the US, but the calendar of applications that are up for Food and Drug Administration actions in July 2025 is notable for the number of novel candi

Many of China’s homegrown first-in-class drugs have had a hard time becoming rainmakers for their originators, with few becoming blockbusters in domestic or international sales terms. Since the first

LEO Pharma A/S may have suffered a setback in the clinic this summer, with a rare skin disease drug failing in Phase III, but the Danish dermatology specialist has enjoyed a strong first half of 2024

LEO Pharma is poised to gain a first approval for Anzupgo, a new topical treatment for moderate to severe chronic hand eczema (CHE) that is set to become a major earner for the Denmark-headquartered